Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Total Liabilities (2016 - 2017)

Historic Total Liabilities for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $11.8 million.

  • Bone Biologics' Total Liabilities rose 5322.9% to $11.8 million in Q3 2017 from the same period last year, while for Sep 2017 it was $11.8 million, marking a year-over-year increase of 5322.9%. This contributed to the annual value of $9.1 million for FY2016, which is N/A changed from last year.
  • Bone Biologics' Total Liabilities amounted to $11.8 million in Q3 2017, which was up 5322.9% from $10.5 million recorded in Q2 2017.
  • Over the past 5 years, Bone Biologics' Total Liabilities peaked at $11.8 million during Q3 2017, and registered a low of $7.5 million during Q1 2016.